한국인 정신분열병 환자에서 COMT 유전자내의 단일염기 다형성 분석

참고문헌 (38)

1. Owen MJ, "Psychiatric genetics and genomics", pp.247~266 (2003), Oxford University Press
2. Faraone SV, "Familial links between schizophrenia and other disorders: application of the multifactorial polygenic model", Psychiatry, 51, pp.37~47 (1988)
3. Karayiorgou M, "A turning point in schizophrenia genetics", Neuron, 19, pp.967~979 (1997)
4. Van Rossum JM, "The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs", Arch Int Pharmacodyn Ther, 160, pp.492~494 (1996)
5. Pulver AE, "Search for schizophrenia susceptibility genes", Biol Psychiat, 47, pp.221~230 (2000)
6. Morrow B, "Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome", Am J Hum Genet, 56, pp.1391~1403 (1995)
7. Yan W, "Chromosome 22q11.2 interstitial deletions among childhoodonset schizophrenics and “multidimensionally impaired”", Am J Med Genet, 81, pp.41~43 (1998)
8. Thomas JA, "Chromosomes 22q11 deletion syndrome: an update and review for the primary pediatrician", Clin Pediatr (Phila), 36, pp.253~266 (1997)
9. Bassett AS, "22q11 deletion syndrome: a genetic subtype of schizophrenia", Biol Psychiatry, 46, pp.882~891 (1999)
10. Tenhunen J, "Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters", Eur J Biochem, 223, pp.1049~1059 (1994)
11. Lundstrom K, "Cloning, expression and structure of catechol-O-methyltransferase", Biochem Biophys Acta, 1251, pp.1~10 (1995)
12. Huotari M, "Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice", J Pharmacol Exp Ther, 303, pp.1309~1316 (2002)
13. Chen J, "Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain", Am J Hum Genet, 75, pp.807~821 (2004)
14. Lotta T, "Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme", Biochemistry, 34, pp.4202~4210 (1995)
15. Lachman HM, "Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders", Pharmacogenetics, 6, pp.243~250 (1996)
16. Egan MF, "Effect of COMT Val108", 158 Met genotype on frontal lobe function and risk for schizophrenia, 2001, pp.98, 6917~6922
17. Ahsan H, "A family-based genetic association study of variants in estrogenmetabolism genes COMT and CYP1B1 and breast cancer risk", Breast Cancer Res Treat, 85, pp.121~131 (2004)
18. Harrison PJ, "Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence", Mol Psychiatry, 10, pp.40~68 (2005)
19. Nolan KA, "Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility", Am J Psychiatry, 161, pp.359~361 (2004)
20. Chen X, "Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families", Mol Psychiatry, 9, pp.962~967 (2004)
21. Shifman S, "A highly significant association between a COMT haplotype and schizophrenia", Am J Hum Genet, 71, pp.1296~1302 (2002)
22. Bray NJ, "A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain", Am J Hum Genet, 73, pp.152~161 (2003)
23. Meyer-Lindenberg A, "Impact of complex genetic variation in COMT on human brain function", Mol Psychiatry, 11, pp.867~877 (2006)
24. Nunokawa A, "No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population", Neurosci Res, 58, pp.291~296 (2007)
25. Chien YL, "Association of the 3’ region of COMT with schizophrenia in Taiwan", J Formos Med Assoc, 108, pp.301~309 (2009)
26. Yu R, "Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study", Am J Med Genet B Neuropsychiatr Genet, 144B, pp.570~573 (2007)
27. Kang SG, "Val-158Met polymorphism in the catechol-O-methyltransferase (COMT) gene is not associated with tardive dyskinesia in schizophrenia", Neuropsychobiology, 57, pp.22~25 (2008)
28. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1994), American Psychiatric Association
29. Li T, "Familybased linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11", Mol psychiatry, 5, pp.77~84 (2000)
30. 김명수, "한국인 정신분열병 및 양극성 기분장애와 Catechol-O-Methyltransferase 유전자 다형성 (Valine", Methionine)과의 연합연구, 2001, pp.40(3), 510~519[DOI]
31. 박태원, "기능성 Catechol-O-Methyltransferase 유전자 다형성과 한국인 정신분열병의 관련성", 신경정신의학, 40(4), pp.708~717 (2001), 대한신경정신의학회
32. 주은정, "한국인에서 COMT 유전자내 단일염기다형성과 정신분열병의 유전적 관련성", 대한정신약물학회지, 14(2), pp.172~180 (2003), 대한정신약물학회
33. Palmatier MA, "Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles", Biol Psychiatry, 46, pp.557~567 (1999)
34. Lee SG, "Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans", Hum Genet, 116, pp.319~328 (2005)
35. Sazci A, "Catechol-Omethyltransferase gene Val108", 158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women, 2004, pp.132, 51~56
36. Boudikova B, "Human liver catechol-O-methyltransferase pharmacogenetics", Clin Pharmacol Ther, 48, pp.381~389 (1990)
37. Gogos JA, "Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior", Proc Natl Acad Sci U S A, 95, pp.9991~9996 (1998)
38. Karayiorgou M, "Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility", Biol Psychiatry, 43, pp.425~431 (1998)

관련 논문AI추천